PeptiMimesis' Seed VC - II Round

PeptiMimesis raised a round of funding on March 15, 2017. Investors include Cap Innov'Est.

PeptiMimesis is a biopharmaceutical company dedicated to the discovery and development of transmembrane therapeutic peptides. The company's proprietary platform aims to deliver a set of drug candidate…

Articles about PeptiMimesis' Seed VC - II Round: